Drug profile · INN
travoprost
TRAVATAN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
travoprost (TRAVATAN) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN travoprost
Brand TRAVATAN
Route OPHTHALMIC
Formulation SOLUTION
ATC code S01ED51
Originator Novartis Pharmaceuticals
Frequently asked questions
What is travoprost?
travoprost (TRAVATAN) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for travoprost?
TRAVATAN is a marketed brand name for travoprost. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of travoprost?
travoprost has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.